Automate Your Wheel Strategy on HOLX
With Tiblio's Option Bot, you can configure your own wheel strategy including HOLX - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol HOLX
- Rev/Share 18.3882
- Book/Share 23.3734
- PB 3.193
- Debt/Equity 0.4805
- CurrentRatio 4.0402
- ROIC 0.0718
- MktCap 16660767260.0
- FreeCF/Share 4.4544
- PFCF 16.6674
- PE 30.7912
- Debt/Assets 0.2745
- DivYield 0
- ROE 0.1101
- Rating B+
- Score 3
- Recommendation Neutral
- P/E Score 2
- DCF Score 4
- P/B Score 2
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Downgrade | HOLX | Argus | Buy | Hold | -- | -- | Jan. 12, 2026 |
| Downgrade | HOLX | Evercore ISI | Outperform | In-line | -- | $78 | Jan. 5, 2026 |
| Downgrade | HOLX | BNP Paribas Exane | Outperform | Neutral | -- | $79 | Nov. 21, 2025 |
| Upgrade | HOLX | Evercore ISI | In-line | Outperform | -- | $78 | Oct. 7, 2025 |
| Upgrade | HOLX | Argus | Hold | Buy | -- | $80 | Aug. 18, 2025 |
| Upgrade | HOLX | RBC Capital Mkts | Sector Perform | Outperform | -- | $87 | Aug. 6, 2025 |
| Upgrade | HOLX | Citigroup | Neutral | Buy | -- | $80 | July 9, 2025 |
| Reiterated | HOLX | Needham | -- | Hold | -- | -- | May 27, 2025 |
| Downgrade | HOLX | Argus | Buy | Hold | -- | -- | March 3, 2025 |
| Downgrade | HOLX | Leerink Partners | Outperform | Market Perform | $80 | $75 | Feb. 6, 2025 |
News
Hologic (HOLX) International Revenue Performance Explored
Published: February 02, 2026 by: Zacks Investment Research
Sentiment: Negative
Review Hologic's (HOLX) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
Read More
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know
Published: February 02, 2026 by: Zacks Investment Research
Sentiment: Positive
Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.
Read More
HOLX Stock Slips on Q1 Earnings and Revenue Miss, Margins Crash
Published: January 30, 2026 by: Zacks Investment Research
Sentiment: Negative
Hologic slips after a Q1 EPS and revenue miss, as gross margin fell 150 bps with Diagnostics weakness offset by strong GYN Surgical growth.
Read More
Stay Ahead of the Game With Hologic (HOLX) Q1 Earnings: Wall Street's Insights on Key Metrics
Published: January 26, 2026 by: Zacks Investment Research
Sentiment: Positive
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Hologic (HOLX), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended December 2025.
Read More
Hologic (HOLX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Published: January 22, 2026 by: Zacks Investment Research
Sentiment: Positive
Hologic (HOLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Read More
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Published: January 22, 2026 by: Zacks Investment Research
Sentiment: Positive
Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP.
Read More
Hologic Q1 Earnings Preview: How Should You Play the Stock Now?
Published: January 22, 2026 by: Zacks Investment Research
Sentiment: Positive
HOLX heads into Q1 earnings with rising EPS and revenue estimates, strong segment momentum and a pending buyout limiting near-term upside.
Read More
Will Hologic (HOLX) Beat Estimates Again in Its Next Earnings Report?
Published: January 21, 2026 by: Zacks Investment Research
Sentiment: Positive
Hologic (HOLX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Read More
Here's Why Hologic (HOLX) is a Strong Momentum Stock
Published: January 21, 2026 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
Published: January 21, 2026 by: Zacks Investment Research
Sentiment: Positive
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Read More
HOLX vs. SYK: Which Medical Device Leader Is a Solid Bet Now?
Published: January 19, 2026 by: Zacks Investment Research
Sentiment: Positive
Hologic and Stryker gear up for earnings with diagnostic wins, surgical growth and strategic moves shaping the medical device race.
Read More
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It
Published: January 16, 2026 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
HOLX vs. SONVY: Which Stock Should Value Investors Buy Now?
Published: January 08, 2026 by: Zacks Investment Research
Sentiment: Positive
Investors interested in Medical - Instruments stocks are likely familiar with Hologic (HOLX) and SONOVA HOLDING (SONVY). But which of these two stocks is more attractive to value investors?
Read More
HOLX or SONVY: Which Is the Better Value Stock Right Now?
Published: January 07, 2026 by: Zacks Investment Research
Sentiment: Positive
Investors interested in Medical - Instruments stocks are likely familiar with Hologic (HOLX) and SONOVA HOLDING (SONVY). But which of these two companies is the best option for those looking for undervalued stocks?
Read More
HOLX vs. SONVY: Which Stock Is the Better Value Option?
Published: January 06, 2026 by: Zacks Investment Research
Sentiment: Positive
Investors interested in stocks from the Medical - Instruments sector have probably already heard of Hologic (HOLX) and SONOVA HOLDING (SONVY). But which of these two stocks presents investors with the better value opportunity right now?
Read More
Hologic's Breast Health Unit Stays In Focus in 2026: What Lies Ahead?
Published: January 06, 2026 by: Zacks Investment Research
Sentiment: Neutral
HOLX's Breast Health unit is back in focus as a proposed Blackstone-TPG deal adds a $76 cash offer and CVR to 2026-27 revenue goals.
Read More
Hologic's GYN Surgical Segment Looks Poised for Long-Term Growth
Published: December 26, 2025 by: Zacks Investment Research
Sentiment: Positive
HOLX's GYN Surgical unit gains momentum as the demand for gynecological devices rises globally, driven by innovation, M&A and strong overseas adoption.
Read More
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock
Published: December 23, 2025 by: Zacks Investment Research
Sentiment: Positive
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Read More
HOLX vs. LH: Which MedTech Stock Is the Stronger Investment Now?
Published: December 22, 2025 by: Zacks Investment Research
Sentiment: Positive
Labcorp's strategic partnerships, specialty test growth and more attractive valuation tilt the balance as it emerges stronger than Hologic right now.
Read More
HOLX's Genius AI Mammography Flags Missed Breast Cancer Cases
Published: December 17, 2025 by: Zacks Investment Research
Sentiment: Negative
Hologic shares dip as the company unveils new study data showing its Genius AI mammography flags 32% of previously missed breast cancer cases.
Read More
Why Hologic (HOLX) is a Top Momentum Stock for the Long-Term
Published: December 17, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
Hologic's Genius AI Detection Shows Value by Spotting Missed Cancers
Published: December 17, 2025 by: Zacks Investment Research
Sentiment: Positive
HOLX's Genius AI Detection flags missed breast cancers, showing promise in improving mammography accuracy and radiologist efficiency.
Read More
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know
Published: December 12, 2025 by: Zacks Investment Research
Sentiment: Positive
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Read More
HOLX Stock Up 16% in 6 Months: Is it Still a Hold Heading Into 2026?
Published: December 08, 2025 by: Zacks Investment Research
Sentiment: Positive
Hologic shares rise 16% in six months, with divisional strength clinical data and a go-private deal shaping the short-term outlook.
Read More
Why Is Hologic (HOLX) Up 1% Since Last Earnings Report?
Published: December 03, 2025 by: Zacks Investment Research
Sentiment: Positive
Hologic (HOLX) reported earnings 30 days ago. What's next for the stock?
Read More
Hologic, Inc. (HOLX) Is a Trending Stock: Facts to Know Before Betting on It
Published: December 01, 2025 by: Zacks Investment Research
Sentiment: Positive
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Read More
HOLX vs. DGX: Which Healthcare Diagnostics Stock Is the Better Bet?
Published: November 27, 2025 by: Zacks Investment Research
Sentiment: Positive
DGX's strong YTD gains and momentum in advanced diagnostics and acquisitions highlight why it may stand out in the competitive testing market against HOLX.
Read More
Here's Why Hologic (HOLX) is a Strong Value Stock
Published: November 26, 2025 by: Zacks Investment Research
Sentiment: Positive
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Read More
New Clinical Evidence Bolsters Hologic's Breast Cancer Technologies
Published: November 26, 2025 by: Zacks Investment Research
Sentiment: Positive
HOLX is set to present new real-world data at RSNA 2025, showing how its AI-driven breast imaging tools boost workflow without sacrificing detection.
Read More
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know
Published: November 18, 2025 by: Zacks Investment Research
Sentiment: Positive
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Read More
About Hologic, Inc. (HOLX)
- IPO Date 1990-03-01
- Website https://www.hologic.com
- Industry Medical - Instruments & Supplies
- CEO Stephen MacMillan
- Employees 7063